A total of 626 patients undergoing a prostaglandininduced abortion, the majority in the second trimester, have been analysed for complications occurring during inpatient treatment. Of the last 155 consecutive patients 143 were critically assessed six to eight weeks after abortion for morbidity occurring during their early recovery period.
Introduction
Several critical analyses have been published recently of the risks associated with termination of pregnancy (Kerslake and Casey, 1967; Loung et al., 1971; Sood, 1971; Stallworthy et al., 1971; Beric et al., 1973) .
Prostaglandins have achieved an accepted place in the management of mid-trimester pregnancy termination. At present in Great Britain the use of these agents is restricted to intravenous or extra-amniotic administration, and the intraamniotic route is permitted for investigational use in certain centres. We report here on an analysis ofthe immediate morbidity associated with abortion induced by the intra-or extra-amniotic administration of prostaglandin F,cx (PGF ,x) or prostaglandin E, (PGE,) in 626 patients and on the results ofcritical prospective assessment six weeks after abortion in 143 patients. These results form part of a survey still in progress.
General Features
Since 1970 more than 700 abortions have been performed with prostaglandins in this unit. During the 12 months ending December 1973 they were used in 95% of mid-trimester abortions, which accounted for 24% of all terminations performed in Oxford. The initial months after the introduction of prostaglandins in 1970 were devoted to-investigation of different doses and routes of administration including intravenous and vaginal administration as well as intra-and extra-amniotic techniques. With the two former routes numbers were small and in some instances documentation incomplete, and, additionally, intravenous and vaginal administration were found to be unacceptable for routine use (Hillier and Embrey, 1972, and unpublished data) . Such cases together with those of patients with missed abortion or hydatidiform moles were therefore excluded from the study, leaving 626 cases for detailed analysis.
Outpatient clinic appointments were arranged for all patients six weeks after abortion, but many defaulted and eamination of the records showed that observations made were often inadequate. In view of this a prospective, and still continuing, survey of patients has been performed in the last eight months with one doctor examining all patients.
The age and marital status of all patients are shown in table I. At the time of abortion 336 patients had had no previous pregnancies, 67 had had one, 83 had had two, 59 had had three, 38 had had four, 24 had had five, and 19 had had six or more. Gestation is charted in relation to the route of prostaglandin administration in table II.
PATIENT MANAGEMENT
Abortions were induced using extra-amniotic or intra-amniotic administration of prostaglandins (table III) . The techniques of administration were standard but with increasing experience the dose and frequency of administration were altered, resulting in a reduction in abortion times. Extra-amniotic administration was performed as described by Embrey et al. (1972) . In most cases intermittent extra-amniotic injections of 200 tug PGE, every two hours (total dose 450-7,650 tug) or 750 Ftg PGF,ac every two hours (total dose 1,750-30,000 tug) were given. In the last eight months of the study 75 patients were given only two injections (500 ,ug-1,500 Fg PGEa) with an interval of six to 12 hours between them. Altogether 66% of the 530 patients given extra-amniotic prostaglandin received adjunctive intravenous oxytocin (80 mU/min) starting four hours after the initial prostaglandin injection. Intra-amniotic administration (total dosage PGE, 10-20 mg, PGF,a 25-50 mg) was described by MacKenzie et al. (1974) . Adjunctive oxytocin therapy (80 mU/ min) was given to compliment uterine activity (Embrey et al., 1973; MacKenzie et al., 1974) 25-1 (4-68) 22 37-3 (5-72) reversion to a conservative policy. All patients were examined bimanually before discharge from hospital. Rhesus-negative patients routinely received anti-D y-globulin during the first 24 hours after abortion unless scheduled for tubal ligation.
Inpatient Observations

MORBIDITY
The commonest side effects were gastrointestinal. Altogether 291 (46 5%) patients vomited on at least one occasion, the incidence being greater in patients treated intra-amniotically (54.2%) than extra-amniotically (34%). Twenty-eight patients had one or more episodes of diarrhoea, which was also more common with intra-amniotic treatment. Lethargy and depression were experienced by four patients, one of whcm was severely depressed and withdrawn before abortion. She was transferred to a psychiatric unit after termination and was discharged two weeks later much improved.
Four patients had cystitis and one a vaginal discharge treated by their general practitioner. Two patients had abdominal pains during the first two weeks after discharge which needed no specific treatment. One patient was admitted to a surgical unit with acute appendicitis four weeks after abortion. 
CONTRACEPTION
The contraceptive methods used before and after abortion are shown in table VI. Four patients were sterilized immediately after abortion and eight others were sterilized before follow up or were awaiting admission for tubal ligation. Appointments at their local family planning clinic were made for all patients who were undecided about future contraception.
Discussion
Immediate and short-term morbidity after abortion has previously been shown to depend upon a patient's physical and socioeconomic status, duration of pregnancy, technique used, and coincident surgery at the time of abortion. The administration of general anaesthesia, the skill of the operator, and the time taken to abort with pharmacological methods are also relevant. All patients in the study group (626) were from the Oxford catchment area, and almost all were in the second trimester of pregnancy (13 or General's figures for 1971 of 3-1%, 22-6%, and 0-5% respectively for patients of 13 or more week's gestation. Though no statistical significance may be attached to the difference this may represent a greater willingness to refer young patients in the middle trimester for abortion when prostaglandin therapy is available. The distribution for other age groups shown in table I was very similar to that in the Registrar General's figures. The proportion of unmarried patients in this survey (61-2%) also differed from the national figures (51 7%) for second trimester patients. The social status of patients was not directly analysed but was probably similar to that of the group of more than 1,000 women from the same catchment area examined by Stallworthy et al. (1971) . Their findings are comparable with the Registrar General's figures for 1971 (Registrar General, 1973) . The distribution of parity was almost identical to that in the Registrar General's figures though the latter embraced patients from all gestational ages.
Results in the present study should be compared cautiously with those of other series because of variation in the criteria of morbidity and differences in the percentage of patients undergoing concomitant sterilization (2-4% in this series compared with 37-6% in the Registrar General's review for patients of similar gestation).
The degree of haemorrhage has been thought to depend upon the duration of pregnancy. Thus, while the overall incidence of haemorrhage in first trimester abortions has been variously estimated at 0-06% to 10% (Stallworthy et al., 1971; Glenc, 1974) other studies have additionally shown that there can be a twofold to tenfold increase after 10 weeks gestation. (Staliworthy et al., 1971; Loung et al., 1971) . In our series, however, there was no conclusive evidence of an increased incidence of haemorrhage with advancing gestation in the second trimester. Haemorrhage of more than 500 ml occurred in 6-1% of our patients, which compares with the 4% of Stewart and Goldstein (1972) and the 18-6% of Stallworthy et al. (1971) in second trimester abortions using pharmacological means. Ballard and Ballard (1971) , however, reported a 1-7% incidence of haemorrhage in second trimester saline-induced abortions.
Cervical laceration involving only the external os was observed in three patients in this series (0 5%) compared with 1-5% in second trimester patients in the series of Stallworthy et al. (1971) . No cervicovaginal fistulae occurred though this has been reported after intra-amniotic hypertonic saline or prostaglandins (BradleyWatson et al., 1973; Wentz et al., 1973; Kajanoja et al., 1974) .
No uterine rupture was observed in this series and we were unable to find any report of this complication after pharmacologically-induced abortion. This is in contrast to its acknowledged incidence in abortions carried out by dilatation and curettage or vacuum aspiration (Kerslake and Casey 1967; Loung et al., 1971; Sood, 1971; Stallworthy et al., 1971) .
Comparison of the incidence of pyrexia in different series is especially difficult because definitions vary and the use of antibiotics is seldom detailed. In the present series a pyrexic episode (a temperature of 38°C or more on one occasion) occurred in 5-4% of patients, and a third of these were given antibiotics. A temperature of 38'C for more than 24 hours was recorded in 35% of second trimester patients treated with hypertonic glucose, aminocrine, or prostaglandins by Stallworthy et al. (1971) , and Ballard and Ballard (1972) noted a 4-8% incidence of pyrexia of unspecified duration in 3,500 patients terminated with intra-amniotic hypertonic saline. Stewart and Goldstein (1972) have shown that pyrexia (38'C or more for at least 12 hours) is dependent on the time taken to achieve abortion, occurring in 6% of patients who take up to 24 hours to abort and in 42% of those who take more than 72 hours to abort.
Because of improved treatment and fewer surgical evacuations the length of stay in hospital was much reduced during the last eight months of the study period. Altogether 90% of patients were discharged within 48 hours during this time compared with 70% in the preceding study period. In terms of turnover of beds and its acceptability to patients this is very desirable. Comparison of our results with those of other studies is difficult because of inadequate detail but Loung et al. (1971) reported that in 1,000 vacuum aspiration terminations (79% of them performed in first trimester) 89% patients stayed in hospital less than 48 hours. The incidence of tubal ligation in our series and theirs was similar. The Registrar General's figures (Registrar General, 1973) show that only about 30% of all patients aborted in N.H.S. institutions in 1971 were discharged within two days, but 27% of these patients were concomitantly sterilized.
Overall, our incidence of operative morbidity was similar to that reported for first trimester abortion and better than that in most series of second trimester abortions.
Complications after discharge from hospital have generally been less well reported than immediate operative morbidity. Significant illness in the early recovery period was rarely observed in our patients though three required readmission for excessive vaginal bleeding. One patient developed pelvic sepsis. The incidence of genital tract infection was similar to the 1%-2% reported by Jurukovski and Sukarov (1971) and Glenc (1974) after first trimester surgical abortion.
The duration of bleeding after abortion was longer than the three to five days reported by Beric et al. (1973) after vacuum aspiration. In most patients menstruation had begun again within six weeks of abortion, and only 18% considered the first loss heavier than normal.
Contraceptive follow up of patients after abortion is of paramount importance and should be regarded as part of the management of each case. Our results and those in a similar group investigated 18 months after abortion (MacKenzie and Hillier, unpublished data) broadly compare with the recent findings of Beard et al. (1974) .
There are many cogent reasons for advising that therapeutic abortion is best performed as early as possible in pregnancy. Nevertheless, the present results indicate that the operative and early morbidity associated with second trimester abortion using intra-or extra-amniotic prostaglandins is comparable with that reported for first trimester termination by vacuum aspiration and is considerably less than in most studies of second trimester abortion using other methods (Department of Health and Social Security, 1974) . This is possibly a reflection of the shorter induction-abortion interval achieved compared with other pharmacological agents. Careful attention to the technique of administration and care of the patient in a specialized unit may also have contributed to the low level of observed morbidity.
